Results 11 to 20 of about 19,665 (228)

Macrophage activation syndrome in a patient with systemic onset of the juvenile idiopathic arthritis

open access: yesRheumatology, 2016
Systemic onset juvenile idiopathic arthritis (sJIA) is defined as arthritis affecting one or more joint usually in the juvenile age group (< 16 years of age) with or preceded by fever of at least 2 weeks duration that is documented to be daily ...
Deepak Jain   +4 more
doaj   +2 more sources

Does systemic-onset juvenile idiopathic arthritis belong under juvenile idiopathic arthritis? [PDF]

open access: yesRheumatology, 2005
'Science is the systematic classification of experience' George Henry Lewes (1817-78), English philosopher, critic, dramatist, scientist. Juvenile idiopathic arthritis (JIA) is prevalent in about 1 in 1000 children. The earliest formal description of this disease was by Sir George Frederick Still in 1897.
Ramanan, AV, Grom, AA
openaire   +4 more sources

Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review

open access: yesThe Turkish Journal of Pediatrics, 2018
Systemic juvenile idiopathic arthritis is a subtype of juvenile idiopathic arthritis and characterized by arthritis and many systemic features like fever, rash, hepatosplenomegaly, lymphadenopathy and serositis.
Mustafa Çakan   +6 more
doaj   +3 more sources

Initial manifestations and clinical course of systemic onset juvenile idiopathic arthritis: A ten-year retrospective study

open access: yesJournal of the Formosan Medical Association, 2012
The diagnosis of systemic onset juvenile idiopathic arthritis (SoJIA) on disease onset is challenging and made mainly by exclusion. This study aimed to investigate the initial clinical and laboratory features of children with SoJIA in Taiwan.
Hu-Yuan Tsai   +5 more
doaj   +2 more sources

Treatment of systemic-onset juvenile arthritis with canakinumab

open access: yesOpen Access Rheumatology: Research and Reviews, 2015
Joachim Peitz, Gerd Horneff Pediatric Rheumatology Centre, Department of General Pediatrics and Neonatology, Asklepios Clinic, Sankt Augustin, Germany Abstract: Treatment of systemic-onset juvenile idiopathic arthritis is challenging, but the ...
Peitz J, Horneff G
doaj   +1 more source

Discrimination of acute lymphoblastic leukemia from systemic-onset juvenile idiopathic arthritis at disease onset

open access: yesClinics, 2011
OBJECTIVE: To assess clinical and laboratory features that differentiate acute lymphoblastic leukemia from systemic juvenile idiopathic arthritis at disease onset. METHODS: Fifty-seven leukemia patients with musculoskeletal involvement, without blasts on
Mirian S. Tamashiro   +5 more
doaj   +2 more sources

CLINICAL CASE OF TOCILIZUMAB USE IN A PATIENT WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

open access: yesПедиатрическая фармакология, 2014
The article presents a case of successful use of a preparation of monoclonal antibodies to interleukin 6 receptors (tocilizumab) at asevere systemic juvenile idiopathic arthritis.
O. L. Lomakina   +4 more
doaj   +2 more sources

Juvenile Idiopathic Arthritis

open access: yesBalkan Medical Journal, 2017
Juvenile idiopathic arthritis is the most common chronic rheumatic disease of unknown aetiology in childhood and predominantly presents with peripheral arthritis.
Kenan Barut   +3 more
doaj   +3 more sources

Review of International Registers of Patients with Systemic Juvenile Idiopathic Arthritis

open access: yesВопросы современной педиатрии, 2017
The article describes the international experience in monitoring of patients with juvenile idiopathic arthritis. The main goal of most existing international registers of children with juvenile idiopathic arthritis is to evaluate various aspects of the ...
Ekaterina I. Alekseeva   +3 more
doaj   +2 more sources

ADALIMUMAB IN TREATMENT OF SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS

open access: yesВопросы современной педиатрии, 2013
A history case of systemic juvenile idiopathic arthritis with early onset and severe clinical case, resistant to treatment with standard immunosuppressive agents is represented in the article.
R. V. Denisova   +10 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy